Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Aktiesnakken
  4. Aktiesnakken — Juni 2016

Aktiesnakken — Juni 2016

Planlagt Fastgjort Låst Flyttet Aktiesnakken
485 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • CeletusC Offline
    CeletusC Offline
    Celetus
    wrote on sidst redigeret af
    #214

    all cause death by 15% and 3 point MACE by 13%

    1 Reply Last reply
    0
    • M Offline
      M Offline
      MUFC_Oberanven
      wrote on sidst redigeret af
      #215

      Via twitter dukker fantatiske Novo nyheder op 🙂

      1 Reply Last reply
      0
      • M Offline
        M Offline
        MUFC_Oberanven
        wrote on sidst redigeret af
        #216

        5% op i morgen på Novo

        1 Reply Last reply
        0
        • CeletusC Offline
          CeletusC Offline
          Celetus
          wrote on sidst redigeret af
          #217

          Enig.

          1 Reply Last reply
          0
          • CeletusC Offline
            CeletusC Offline
            Celetus
            wrote on sidst redigeret af
            #218

            imponerende produkt

            1 Reply Last reply
            0
            • M Offline
              M Offline
              MUFC_Oberanven
              wrote on sidst redigeret af
              #219

              New Orleans, US, 13 June 2016 – Novo Nordisk today announced that Victoza® (liraglutide) significantly reduced the risk of the composite primary endpoint of cardiovascular (CV) death, non-fatal myocardial infarction (heart attack) or non-fatal stroke by 13% vs placebo (95% confidence interval [CI]: 0.78; 0.97, p=0.01), when added to standard of care in 9,340 adults with type 2 diabetes at high CV risk. The main results of the LEADER trial were presented today at the American Diabetes Association

              1 Reply Last reply
              0
              • M Offline
                M Offline
                MUFC_Oberanven
                wrote on sidst redigeret af
                #220

                There was a significant 22% reduction in cardiovascular death with Victoza® treatment vs placebo (95% CI: 0.66; 0.93, p=0.007) and reductions in non-fatal myocardial infarction (HR=0.88, 95% CI: 0.75; 1.03, p=0.11) and non-fatal stroke (HR=0.89, 95% CI: 0.72; 1.11, p=0.30).1, 2

                1 Reply Last reply
                0
                • Den_FattigeD Offline
                  Den_FattigeD Offline
                  Den_Fattige
                  wrote on sidst redigeret af
                  #221

                  Er det godt eller skide godt ??

                  1 Reply Last reply
                  0
                  • Helge_LarsenPI-redaktørH Offline
                    Helge_LarsenPI-redaktørH Offline
                    Helge_LarsenPI-redaktør
                    wrote on sidst redigeret af
                    #222

                    http://www.proinvestor.com/aktienyt/HUG2020216/Victoza®-viser-signifikant-reduktion-af-risikoen-for-alvorlige-kardiovaskulaere-haendelser-og-doed-hos-voksne-med-type-2-diabetes-i-LEADER-studiet

                    1 Reply Last reply
                    0
                    • M Offline
                      M Offline
                      MUFC_Oberanven
                      wrote on sidst redigeret af
                      #223

                      Åbenbart så er disse Victoza Data nok som forventet.

                      1 Reply Last reply
                      0
                      • Helge_LarsenPI-redaktørH Offline
                        Helge_LarsenPI-redaktørH Offline
                        Helge_LarsenPI-redaktør
                        wrote on sidst redigeret af
                        #224

                        God morgen. 🙂

                        1 Reply Last reply
                        0
                        • Helge_LarsenPI-redaktørH Offline
                          Helge_LarsenPI-redaktørH Offline
                          Helge_LarsenPI-redaktør
                          wrote on sidst redigeret af
                          #225

                          En god gennem omkring data på Victosa. http://www.proinvestor.com/investornyt/377774/novo-victoza-vaekker-laeger-og-diabetikere-til-live

                          1 Reply Last reply
                          0
                          • Helge_LarsenPI-redaktørH Offline
                            Helge_LarsenPI-redaktørH Offline
                            Helge_LarsenPI-redaktør
                            wrote on sidst redigeret af
                            #226

                            gennemgang

                            1 Reply Last reply
                            0
                            • LivermoreL Offline
                              LivermoreL Offline
                              Livermore
                              wrote on sidst redigeret af
                              #227

                              I forhold til forventningerne fra Citigroup er data lidt skuffende: https://www.landbobanken.dk/investering/aktiefokus

                              1 Reply Last reply
                              0
                              • TeamGarlicT Offline
                                TeamGarlicT Offline
                                TeamGarlic
                                wrote on sidst redigeret af
                                #228

                                Godmorgen fellas

                                1 Reply Last reply
                                0
                                • M Offline
                                  M Offline
                                  MUFC_Oberanven
                                  wrote on sidst redigeret af
                                  #229

                                  Fra Danske Bank: "NOVO NORDISK: robust data from Leader trail, 13% reduction for GPP-1 even if
                                  we hoped for a bit more good enough, +tive effect on all CV
                                  endpoints. We reiterate BUY & TP 470."

                                  1 Reply Last reply
                                  0
                                  • O Offline
                                    O Offline
                                    OHW
                                    wrote on sidst redigeret af
                                    #230

                                    Nu er det svært at spå især om fremtiden men mine forventninger til i dag er, at 1100 niveau skal testes endnu en gang. Afvises den endnu en gang, så er der gode mulighed for, at vi får lidt ro på indtil i næste uge, hvor brexit meningsmålingerne vil styre kursen.

                                    1 Reply Last reply
                                    0
                                    • LivermoreL Offline
                                      LivermoreL Offline
                                      Livermore
                                      wrote on sidst redigeret af
                                      #231

                                      Ja, det er svært at forudsige fremtiden, men ganske meget tyder nu på et Brexit. Og så kan alt ske.

                                      1 Reply Last reply
                                      0
                                      • J Offline
                                        J Offline
                                        JohnW
                                        wrote on sidst redigeret af
                                        #232

                                        Jeg synes måske nok NOVO får en urimelig medfart idag. Er pt. nede 3,8% hvor dax kun er nede 0,7%

                                        1 Reply Last reply
                                        0
                                        • M Offline
                                          M Offline
                                          Mcjean
                                          wrote on sidst redigeret af
                                          #233

                                          Har ikke lakseaktier men ser at mange har herinde, måske denne her skal læseshttp://www.xtrainvestor.com/en/content/14juni-lakseproblemer-storebrand-avst%C3%A5r-retter-i-funcom-brexit-oljeservice-fredriksens-vlcc

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper